VALALTO
LIVE

Serial Number

79441971

Owner

MEDIOLANUM FARMACEUTICI S.p.A.

Attorney

John Zaccaria

Filing Date

Nov 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VALALTO Trademark

Serial Number: 79441971

VALALTO is a trademark filed by MEDIOLANUM FARMACEUTICI S.p.A. on November 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

MEDIOLANUM FARMACEUTICI S.p.A. (19 trademarks)

VIA S.G. Cottolengo 15/31
20143 Milano , IT

Entity Type: 99

Trademark Details

Filing Date

November 19, 2025

Registration Date

Not Registered

Goods & Services

Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; advertising services

Arranging and conducting of in-person educational forums in the field of pharmaceuticals; Educational services in the nature of pharmaceuticals schools; providing information in the field of education; providing online electronic publications, not downloadable, namely, brochures in the field of pharmaceuticals; arranging and conducting of conferences in the field of pharmaceuticals; arranging and conducting of congresses in the field of pharmaceuticals; arranging and conducting of colloquiums in the field of pharmaceuticals; arranging and conducting of seminars in the field of pharmaceuticals; arranging and conducting of symposiums in the field of pharmaceuticals

Dietetic foods adapted for medical purposes; teeth filling material; herbicides; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; pharmaceutical preparations for the treatment of neuroendocrine disorders; fungicides; food for babies; dietetic substances in the nature of dietetic foods adapted for medical use; disinfectants; nutritional supplements for medical purposes; homogenized food adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; Food supplements, namely, anti-oxidants; dietetic beverages adapted for medical purposes; vitamin supplement patches; dietary fibre supplements; glycerine for medical purposes; immunostimulants; protein dietary supplements; mineral dietary supplements; dietary supplements for human beings; medicated lotions for pharmaceutical purposes; narcotics being pharmaceuticals for the treatment of pain; opiates being pharmaceuticals for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of cancer; Pharmaceutical preparations in the form of pastilles for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; Pharmaceutical preparations in the form of pastilles for the treatment of neuroendocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes for the treatment of pain; chemical preparations for pharmaceutical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for pharmaceutical purposes for the treatment of neuroendocrine disorders; chemical preparations for medical purposes for the treatment of cancer; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of neuroendocrine disorders; Aloe vera preparations for pharmaceutical purposes; phytotherapy preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer-related conditions; vitamin preparations; chemico-pharmaceutical preparations for the treatment of cancer; chemico-pharmaceutical preparations for the treatment of pain; chemico-pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemico-pharmaceutical preparations for the treatment of neuroendocrine disorders

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2026 TROA
REFUSAL PROCESSED BY IB
Jun 4, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 1, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 22, 2026 REPR